📰 Sponsored Level News
Page 2 - Sponsored Level News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sponsored Level. Real-time updates on events, politics, business and more.
July 19, 2023
European Commission determines not to grant marketing authorization approval for palovarotene for fibrodysplasia ossificans progressiva Decision follows negative opinion by the Committee for Medicinal...
July 19, 2023
European Commission determines not to grant marketing authorization approval for palovarotene for fibrodysplasia ossificans progressiva (FOP)Decision...
July 10, 2023
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the...
June 30, 2023
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to placebo Elafibranor was well tolerated with a safety profile consistent with previous studies Resu...
June 29, 2023
Advisory committee voted 10 for and 4 against that evidence from the Phase III MOVE study show palovarotene is an effective treatment in patients with the...
June 13, 2023
Approval heralds the second rare cholestatic liver disease indication for Bylvay in the U.S. after progressive familial intrahepatic cholestasis related pruritus in 2021 Immediate U.S. commercial... | June 13, 2023
June 12, 2023
Seven abstracts to be presented demonstrating treatment effects of Bylvay® in two cholestatic liver diseases, progressive familial intrahepatic cholestasis and Alagille syndrome Data to be... | June 12, 2023
June 1, 2023
01.06.2023 - REGULATED INFORMATION Ipsen initiates a share buy-back programto cover its free employee share-allocation plan Paris (France), 1 June 2023 - Ipsen (Euronext: IPN; ADR: IPSEY) has appointed an investment-services provider to purchase an aggregate ...
May 31, 2023
REGULATED INFORMATION Description of the regulatory framework of the share repurchase programproposed by the Board of Directors to be approved at theCombined Shareholders’ Meeting... | May 31, 2023
May 31, 2023
REGULATED INFORMATION COMBINED SHAREHOLDERS’ MEETING OF IPSEN S.A.HELD ON 31 MAY 2023 ALL THE RESOLUTIONS SUBMITTED TO THE SHAREHOLDERS’ VOTE HAVE BEEN APPROVED Paris , 31 May... | May 31, 2023